Business Wire

Ant International Collaborates with Brazilian Partners to Drive Financial Inclusion with Innovative Credit Tech Solutions

Share

Ant International, a digital payment and financial technology leader, today announced its strategic initiative to provide AI-driven credit technology solutions designed to empower local partners and advance financial inclusions in Brazil.

As a major milestone, Ant International has formed a strategic partnership with Dock, a leader in payments and banking technology in Latin America. This collaboration aims to enhance the credit management capability and infrastructure efficiency for Dock’s clients, which include financial institutions, retailers, fintech start-ups, etc. The shared vision is to make credit services more inclusive for market segments that are currently insufficiently served, such as micro, small and medium-sized enterprises (MSMEs).

In the initial phase of the collaboration, Ant International’s AI-driven credit tech solutions, including an automated and intelligent risk management engine, will be explored for integration into Dock One platform. This initiative aims to strengthen Dock’s offerings in credit operations and infrastructure. By adopting these advanced solutions, clients are expected to optimize their credit decision processes, increase underwriting efficiency and reduce costs. In addition, the partnership will allow the refinement of risk models and credit policies, leading to more precise assessments in their credit operations. Consequently, clients will be better positioned to serve a wider audience. This will open up new opportunities for growth and contribute to broader economic development in the region.

In recent years, Brazil has made significant progress in financial inclusion. However, there’re still opportunities to further support MSMEs and financially constrained groups. In response, Brazil is actively encouraging the digital transformation and innovation of financial services to boost financial accessibility.

Since 2022, Dock has been amplifying the conversation in the market about the need for a new credit paradigm, which considers the particularities of Brazil. By combining Ant International’s advanced credit tech solutions with Dock’s operational expertise and strong market presence, this partnership will elevate the services Dock delivers to local institutions, helping them strengthen credit operations and optimize infrastructure.

"Ant International is the partner we were looking for to materialize our financial inclusion goals. As we do on all our fronts of action, we seek partners who provide the most advanced technologies on the market and allow us to deliver this to our clients, integrating this technology on our platform Dock One. We will use technology to challenge the status quo in this sense and make credit more accessible," explains Antonio Soares, CEO of Dock. "Our intention is, together with Ant International, to put solutions on the market that will significantly expand access to credit and take us to the next step of financial inclusion."

"Brazil is leading the way in financial innovation and inclusion, and Ant International is excited to team with Dock in this dynamic market," said Quan Yu, General Manager of Global Credit Tech, Ant International. "The partnership underscores our commitment to broadening financial accessibility and availability by providing local institutions with AI-driven technologies to better support underserved businesses and communities. We believe in the power of collaboration in promoting financial inclusion and are exploring more partnerships with industry leaders in the region."

About Ant International

Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realise their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.

To learn more, please visit: https://www.antglobal.com/

About Dock

Dock provides technology for payments and banking in Latin America. A pioneer and forerunner, it is the engine behind the acceleration of digital financial services in the region. For more than 20 years, it has fulfilled its mission of democratizing access to financial services, promoting the inclusion of millions of unbanked and underbanked people.

With decades of experience, Dock launched Dock One, the only end-to-end platform in Latin America that brings together card issuance, digital banking, credit, risk and acquiring solutions, accelerating the ability of companies to offer innovative services to their customers. Dock manages the technology, operations, and regulatory complexity so customers can focus on growing their business. The company operates 70 million active accounts and more than eight billion annual transactions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240830566922/en/

Contacts

Ant International
Janice Chen | Ant International
janicechen.cyh@antgroup.com

Taynara Duarte | LLYC
(11) 97514-1832
tduarte@llyc.global

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Adtran sets new SBTi targets for net-zero emissions9.9.2024 15:00:00 EEST | Press release

Adtran today announced its new Science Based Targets initiative (SBTi) commitments. The company aims to achieve net-zero emissions across its entire value chain by 2048, aligning with the global objective of limiting warming to 1.5°C to mitigate the most severe impacts of climate change. Adtran’s newly approved commitments include a 74.5% reduction in absolute scope 1 and 2 greenhouse gas emissions by 2032 and scope 3 emissions by 40% within the same timeframe. These science-based targets underscore Adtran’s dedication to sustainability leadership, as well as its continuous efforts to reduce its own carbon footprint and that of its customers. “Our newly approved SBTi commitments underline our steadfast commitment to climate responsibility and represent a significant step forward in our environmental efforts. When we look at the sustainability gains we’ve already made as a result of joining the SBTi, we’re in no doubt we can realize our goal of organization-wide carbon neutrality,” said

First Patients Dosed in Debiopharm's Phase III Trial (LIBELULA) Investigating Debio 4326, a 12-Month Triptorelin Formulation for Children with Central Precocious Puberty9.9.2024 15:00:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to develop innovative therapies and to improve patient quality of life, today announced the dosing of the first sentinel patients in its open-label, single-arm, multi-center Phase III study, NCT06129539 ‘A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULA)’.Triptorelin is an established treatment for CPP as a 1-, 3- and 6-month formulation. This new phase III study evaluating the novel 12-month triptorelin formulation is being carried out in North and South America. In pursuit of developing safe, effective, and convenient treatment options for patients, Debiopharm, is applying its expertise in extended-release formulations to achieve the first yearly injectable Gonadotropin-Releasing Hormone agonist (GnRHa). Reducing treatment burden while preserv

Scientist.com and Evotec Partner to Accelerate Drug Discovery and Development9.9.2024 14:55:00 EEST | Press release

Scientist.com, the leading research platform for the pharmaceutical industry, has announced a new partnership with Evotec SE, a leading drug discovery and development company. Through this collaboration, Evotec’s comprehensive suite of R&D services, spanning the entire drug discovery and development process, will now be available to registered users on Scientist.com’s award-winning digital marketplace. "At Evotec, our mission is to deliver high-quality, efficient, and innovative drug discovery services that advance the work of researchers developing novel treatments," said Dr. Matthias Evers, Chief Business Officer of Evotec. "By partnering with Scientist.com, we can expand our reach and empower more scientists in their efforts to bring new therapies to market." Evotec offers the Scientist.com research community access to an extensive array of proprietary technologies, including cutting-edge in vitro and in vivo pharmacology, high-throughput screening, and a comprehensive suite of next

BeiGene Announces Updates to Commercial Leadership Team9.9.2024 14:00:00 EEST | Press release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25. “We are excited to welcome Matt, who brings a wealth of global pharmaceutical experience, including leading the commercialization of blockbuster franchises at multiple multinational companies,” said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. “Matt’s management will be pivotal as we continue our leadership in hematology with BRUKINSA and replicate that success in solid tumors, with a deep and exciting pipeline of innovative therapies.” Mr. Shaulis is a global commercial executive with over 20 years of experience at biopharmaceutical companies such as Hansa Biopharma, Pfizer, Teva, Cephalon, and Johnson & Johnson. While at Pfizer, he directed the U.S. commercialization of blockbuster therapies IBRANCE® and XTANDI® as well as leading Pfizer’s acquisition and integration of Medivation. Mr

LuminUltra Acquires Legionella Testing Business from Genomadix and Inks Strategic License to Commercialize Additional Tests for Ultra-portable Molecular Diagnostic Platform9.9.2024 14:00:00 EEST | Press release

LuminUltra (luminultra.com), the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets of Genomadix Inc (genomadix.com), along with rights to develop and commercialize further assays and test methods in water, energy and food and beverage markets globally using the Genomadix Cube™ qPCR (quantitative polymerase chain reaction) Platform. With this transaction, LuminUltra further expands its industry-leading portfolio of molecular testing solutions for rapid identification and quantification of the microbes within residential, commercial and industrial water systems that are responsible for causing the potentially deadly Legionnaire’s disease. When paired with its easy-to-use automated test kit, the Genomadix Cube thermocycling platform will generate results that measure the presence and quantity of Legionella contamination in under one hour with laboratory-grade sensitivity. The elegant simplicity of the system allows an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye